Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-15
2008-01-15
Coleman, Brenda L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S280000, C544S230000
Reexamination Certificate
active
11005797
ABSTRACT:
The present invention relates to 2,6,7-substituted pyrrolo[2,3-d]pyrimidines which inhibit the extracellular release of inflammatory cytokines, said cytokines responsible for one or more human or higher mammalian disease states. The present invention further relates to compositions comprising said 2,6,7-substituted pyrrolo[2,3-d]pyrimidines and methods for preventing, abating, or otherwise controlling enzymes which are understood to be the active components responsible for the herein described disease states.
REFERENCES:
patent: WO 03/074530 (2003-09-01), None
Bookland Roger Gunnard
Brugel Todd Andrew
Clark Michael Philip
De Biswanath
Golebiowski Adam
Coleman Brenda L.
Moore Susanna
Paul Andrew A.
The Procter & Gamble & Company
LandOfFree
Pyrrolo[2,3-d]pyrimidine cytokine inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolo[2,3-d]pyrimidine cytokine inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolo[2,3-d]pyrimidine cytokine inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3917228